|
|
|
Hot Off The Press (January/February/March 2010)
About 2,000 new publications are added to the PSC Literature database every month. This month we'd like to highlight recent developments in primary sclerosing cholangitis, autoimmune pancreatitis, autoimmune hepatitis, and inflammatory bowel disease. Here are our picks for 20 significant articles published in January/February/March 2010:
-
Abreu MT. Toll-like receptor signalling in the intestinal epithelium: how bacterial recognition shapes intestinal function.
Nat. Rev. Immunol. 10: 131-144 (2010).
-
Balasa A, Gathungu G, Kisfali P, Smith EO, Cho JH, Melegh B, Kellermayer R. Assessment of DNA methylation at the interferon regulatory factor 5 (IRF5) promoter region in inflammatory bowel diseases.
Int. J. Colorectal Dis. Feb 2 [Epub ahead of print] (2010).
-
Blaschitz C, Raffatellu M. Th17 cytokines and the gut mucosal barrier.
J. Clin. Immunol. Feb 2 [Epub ahead of print] (2010).
-
Bol-Schoenmakers M, Fiechter D, Raaben W, Hassing I, Bleumink R, Kruijswijk D, Maijoor K, Tersteeg-Zijderveld M, Brands R, Pieters R. Intestinal alkaline phosphatase contributes to the reduction of severe intestinal epithelial damage.
Eur. J. Pharmacol. Feb 1 [Epub ahead of print] (2010).
-
Borcherding F, Nitschke M, Hundorfean G, Rupp J, von Smolinski D, Bieber K, van Kooten C, Lehnert H, Fellermann K, Buning J. The CD40-CD40L pathway contributes to the proinflammatory function of intestinal epithelial cells in inflammatory bowel disease.
Am. J. Pathol. Feb 4 [Epub ahead of print] (2010).
-
Casswall TH, Nemeth A, Nilsson I, Wadstrom T, Nilsson HO. Helicobacter species DNA in liver and gastric tissues in children and adolescents with chronic liver disease.
Scand. J. Gastroenterol. 45: 160-167 (2010).
-
Chai PF, Lee WS, Brown RM, McPartland JL, Foster K, McKiernan PJ, Kelly DA. Childhood autoimmune liver disease: indications and outcome of liver transplantation.
J. Pediatr. Gastroenterol. Nutr. Jan 27 [Epub ahead of print] (2010).
-
Chapman R, Fevery J, Kalloo A, Nagorney DM, Boberg KM, Shneider B, Gores GJ. Diagnosis and management of primary sclerosing cholangitis.
Hepatology 51: 660-678 (2010).
-
Chapman RW. Primary sclerosing cholangitis: what is the role of ursodeoxycholic acid in therapy for PSC?
Nat. Rev. Gastroenterol. Hepatol. 7: 74-75 (2010).
-
Hyslop WB, Kierans AS, Leonardou P, Fritchie K, Darling J, Elazazzi M, Semelka RC. Overlap syndrome of autoimmune chronic liver diseases: MRI findings.
J. Magn. Reson. Imaging 31: 383-389 (2010).
-
Jurgens M, Laubender RP, Hartl F, Weidinger M, Seiderer J, Wagner J, Wetzke M, Beigel F, Pfennig S, Stallhofer J, Schnitzler F, Tillack C, Lohse P, Goke B, Glas J, Ochsenkuhn T, Brand S. Disease activity, ANCA, and IL23R genotype status determine early response to infliximab in patients with ulcerative colitis.
Am. J. Gastroenterol. Mar 2 [Epub ahead of print] (2010).
-
Karlsen TH, Schrumpf E, Boberg KM. Update on primary sclerosing cholangitis.
Dig. Liver Dis. Feb 19 [Epub ahead of print] (2010).
-
Karpen SJ, Trauner M. The new therapeutic frontier - nuclear receptors and the liver.
J. Hepatol. 52: 455-462 (2010).
-
Kaser A, Zeissig S, Blumberg RS. Inflammatory bowel disease.
Annu. Rev. Immunol. Jan 6 [Epub ahead of print] (2010).
-
Khosroshahi A, Bloch DB, Deshpande V, Stone JH. Rituximab therapy leads to rapid decline of serum IgG4 levels and prompt clinical improvement in IgG4-related systemic disease.
Arthritis Rheum. Feb 26 [Epub ahead of print] (2010).
-
Ko SB, Mizuno N, Yatabe Y, Yoshikawa T, Ishiguro H, Yamamoto A, Azuma S, Naruse S, Yamao K, Muallem S, Goto H. Corticosteroids correct aberrant CFTR localization in the duct and regenerate acinar cells in autoimmune pancreatitis.
Gastroenterology Jan 14 [Epub ahead of print] (2010).
-
Koyabu M, Uchida K, Miyoshi H, Sakaguchi Y, Fukui T, Ikeda H, Takaoka M, Hirohara J, Nishio A, Uemura Y, Uemoto S, Okazaki K. Analysis of regulatory T cells and IgG4-positive plasma cells among patients of IgG4-related sclerosing cholangitis and autoimmune liver diseases.
J. Gastroenterol. Jan 20 [Epub ahead of print] (2010).
-
Low A, Love M, Walt R, Kane K, Eksteen B, Goh J. Understanding of chemoprophylaxis and concordance in inflammatory bowel disease.
World J. Gastroenterol. 16: 578-582 (2010).
-
Mair M, Zollner G, Schneller D, Musteanu M, Fickert P, Gumhold J, Schuster C, Fuchsbichler A, Bilban M, Tauber S, Esterbauer H, Kenner L, Poli V, Blaas L, Kornfeld JW, Casanova E, Mikulits W, Trauner M, Eferl R. Stat3 protects from liver injury and fibrosis in a mouse model of sclerosing cholangitis.
Gastroenterology Feb 26 [Epub ahead of print] (2010).
-
Navaneethan U, Shen B. Hepatopancreatobiliary manifestations and complications associated with inflammatory bowel disease.
Inflamm. Bowel Dis. Mar 2 [Epub ahead of print] (2010).
|
|
David and Judy Rhodes
Last Update: 03/06/10
| | |
